Misplaced Pages

Draft:Bias Capital: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 00:32, 17 December 2024 editBrandon (talk | contribs)Edit filter managers, Administrators22,627 edits Nominated for deletion; see Misplaced Pages:Articles for deletion/Bias Capital.Tag: Twinkle← Previous edit Revision as of 03:29, 17 December 2024 edit undoInternetArchiveBot (talk | contribs)Bots, Pending changes reviewers5,387,807 edits Rescuing 2 sources and tagging 0 as dead.) #IABot (v2.0.9.5) (Eastmain - 22112Next edit →
Line 15: Line 15:
}} }}


'''Bias Capital, LLC''' (commonly known as '''Bias Capital''') is an American ] that invests in both early-stage ] and established ]. In addition to its primary investments, the firm operates an ], offering ] and ] the opportunity to access and participate in select investment opportunities.<ref>{{Cite web |date=2021-10-06 |title=Bias Capital |url=https://web.archive.org/web/20211006182734/http://bias.capital/ |access-date=2024-12-16 |website=web.archive.org}}</ref> '''Bias Capital, LLC''' (commonly known as '''Bias Capital''') is an American ] that invests in both early-stage ] and established ]. In addition to its primary investments, the firm operates an ], offering ] and ] the opportunity to access and participate in select investment opportunities.<ref>{{Cite web |date=2021-10-06 |title=Bias Capital |url=http://bias.capital/ |access-date=2024-12-16 |website=web.archive.org |archive-date=2021-10-06 |archive-url=https://web.archive.org/web/20211006182734/http://bias.capital/ |url-status=bot: unknown }}</ref>


Bias Capital operates as the venture capital arm of ]. Bias Capital operates as the venture capital arm of ].


== Notable Investments == == Notable Investments ==
In July 2023, Bias Capital led a $25 million ] funding round for ], a biotech company focused on revolutionizing ] and healthcare management.<ref>{{Cite news |title=Parker Health Secures $25 Million in Series A Funding to Transform American Healthcare |url=https://www.businesswire.com/news/home/20230712832557/en/Parker-Health-Secures-25-Million-in-Series-A-Funding-to-Transform-American-Healthcare |archive-url=http://web.archive.org/web/20241005112855/https://www.businesswire.com/news/home/20230712832557/en/Parker-Health-Secures-25-Million-in-Series-A-Funding-to-Transform-American-Healthcare |archive-date=2024-10-05 |access-date=2024-12-13 |language=en}}</ref> In July 2023, Bias Capital led a $25 million ] funding round for ], a biotech company focused on revolutionizing ] and healthcare management.<ref>{{Cite news |title=Parker Health Secures $25 Million in Series A Funding to Transform American Healthcare |url=https://www.businesswire.com/news/home/20230712832557/en/Parker-Health-Secures-25-Million-in-Series-A-Funding-to-Transform-American-Healthcare |archive-url=https://web.archive.org/web/20241005112855/https://www.businesswire.com/news/home/20230712832557/en/Parker-Health-Secures-25-Million-in-Series-A-Funding-to-Transform-American-Healthcare |archive-date=2024-10-05 |access-date=2024-12-13 |language=en |url-status=live }}</ref>


Other notable investments include Grabango, ], Fintor, Valtivis, Flower CO. and FLYR.<ref>{{Cite web |title=Bias Capital Investment Portfolio {{!}} PitchBook |url=https://pitchbook.com/profiles/investor/518094-64#investments |access-date=2024-12-16 |website=pitchbook.com |language=en}}</ref> Other notable investments include Grabango, ], Fintor, Valtivis, Flower CO. and FLYR.<ref>{{Cite web |title=Bias Capital Investment Portfolio {{!}} PitchBook |url=https://pitchbook.com/profiles/investor/518094-64#investments |access-date=2024-12-16 |website=pitchbook.com |language=en}}</ref>

Revision as of 03:29, 17 December 2024

This template is being used in the wrong namespace. To nominate this talk page for deletion, go to Miscellany for deletion.

An editor has nominated this article for deletion.
You are welcome to participate in the deletion discussion, which will decide whether or not to retain it.Feel free to improve the article, but do not remove this notice before the discussion is closed. For more information, see the guide to deletion.
Find sources: "Bias Capital" – news · newspapers · books · scholar · JSTOR%5B%5BWikipedia%3AArticles+for+deletion%2FBias+Capital%5D%5DAFD
Bias Capital
Company typePrivate
IndustryVenture capital
FoundedFebruary 2021; 3 years ago (2021-02)
FounderMaximillian Naza
HeadquartersSan Francisco, California, U.S.
ProductsInvestments
Websitehttps://bias.capital/

Bias Capital, LLC (commonly known as Bias Capital) is an American venture capital firm that invests in both early-stage start-ups and established growth companies. In addition to its primary investments, the firm operates an angel syndicate, offering accredited investors and qualified purchasers the opportunity to access and participate in select investment opportunities.

Bias Capital operates as the venture capital arm of PasciVite.

Notable Investments

In July 2023, Bias Capital led a $25 million Series A funding round for Parker Health, a biotech company focused on revolutionizing electronic health records and healthcare management.

Other notable investments include Grabango, Wayflyer, Fintor, Valtivis, Flower CO. and FLYR.

References

  1. "Bias Capital". web.archive.org. 2021-10-06. Archived from the original on 2021-10-06. Retrieved 2024-12-16.{{cite web}}: CS1 maint: bot: original URL status unknown (link)
  2. "Parker Health Secures $25 Million in Series A Funding to Transform American Healthcare". Archived from the original on 2024-10-05. Retrieved 2024-12-13.
  3. "Bias Capital Investment Portfolio | PitchBook". pitchbook.com. Retrieved 2024-12-16.
Categories: